Refining the Role of Surgery in De Novo Stage IV Breast Cancer: the Need for Biomarkers and Mechanistic Insights
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Tokunaga E, Koi Y, Tajiri W, Koga C, Ijichi H, Akiyoshi S
. The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer. Breast Cancer. 2025; 32(2):426-433.
PMC: 11842408.
DOI: 10.1007/s12282-025-01675-w.
View
2.
Gera R, Chehade H, Wazir U, Tayeh S, Kasem A, Mokbel K
. Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis. Sci Rep. 2020; 10(1):2952.
PMC: 7031518.
DOI: 10.1038/s41598-020-59908-1.
View
3.
Zhang Q, Cai Z, Gerratana L, Davis A, DAmico P, Chawla A
. Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA. Clin Cancer Res. 2024; 30(16):3470-3480.
DOI: 10.1158/1078-0432.CCR-24-0535.
View
4.
Piranlioglu R, Lee E, Ouzounova M, Bollag R, Vinyard A, Arbab A
. Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model. Nat Commun. 2019; 10(1):1430.
PMC: 6441000.
DOI: 10.1038/s41467-019-09015-1.
View